North America Bioreactors Market to Grow at a CAGR of 7.5% to reach US$ 2,102.75 Mn from 2020 to 2027

North America Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country

  • Report Code : TIPRE00011475
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Buy Now

The North Americabioreactors marketis expected to reach US$ 2,102.75 Mn by 2027 from US$ 1,188.50 Mn in 2019; the market is estimated to grow at a CAGR of 7.5%during 2020–2027.

The increasing adoption of single-use bioreactors and rapidly growing demand for bioreactors from biopharmaceutical and biotechnology industries are among the major factors driving the growth of the market in North America. However, stringent regulatory frameworks in different countriesrestrain the North America Bioreactors market growth to a certain extent.

A bioreactor is equipment or system engineered to provide biologically active environment for the production of various medical and pharmaceutical compounds. The vessel is used to carry out a chemical process, which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. The bioreactors are commonly cylindrical, ranging in size from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells.

The pharmaceutical industry has been growing at an unprecedented pace in recent years. The strong demand for biologics and biosimilars has driven the growth of the industry. The biopharmaceuticals industry is one of the most significant contributors to the economy of many countries. The US is the largest market for biopharmaceuticals and leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), the US firms conduct over half the world's total pharmaceutical R&D (worth US$ 75 billion) and hold the highest number of patents in new medicines. The increasing number of biologics approvals, growing pipeline of biosimilars, and mounting investments in research activities are prime factors facilitating the growth of the industry.

Advancements in the field of bioreactors have opened many opportunities for the bioreactor market players. Leading players have been coming up with innovative products since the last few years. The improvements in bioreactors aid in the faster and easier production of biopharmaceuticals at reduced production costs. For instance, Pall Corporation launched the mPath bioreactor control systemsthat provide accurate measurement and control of single-use process development-scale bioprocesses.

Presently, various biopharma companies, research institutes, and pharmaceutical and biotech companies are engaged in conducting collaborative work to address the global issue of COVID-19 outbreak. This has eventually shifted their focus from new drugdevelopment to vaccine development against this virus strain. However, the diversion of resources from liposome-based drugs development to COVID-19 therapeutics and ventilators, among others, is likely to hamper overall productivity of the drug development industries in the next few years. However, exceptthe manufacturing and sales operations in the bioreactors industry,theutilization of bioreactors, have tremendously increased. For instance, researchers in California are using the bioreactors to analyze the activities of virus, which might assist them in vaccine discovery. These factors are projected to drive the adoption of bioreactors during post-pandemic period in North America.

Mexico Bioreactors Market,Revenue and Forecast to 2027 (US$Mn)

Mexico Bioreactors Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

NORTH AMERICABIOREACTORS MARKET SEGMENTATION

By Cell

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Others

By Molecule

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Stem Cells
  • Gene Therapy
  • Others

By Technology

  • Wave-Induced Motion SUB
  • Stirred SUB
  • Single-Use Bubble Column
  • Others

By Country

  • US
  • Canada
  • Mexico

Companies Mentioned

  • Thermo Fisher Scientific Inc
  • Pall Corporation
  • PBS Biotech,Inc
  • General Electric Company
  • MERCK KGaA
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Cell, Molecule, Technology, End User and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

The List of Companies - North America Bioreactors Market

  1. Thermo Fisher Scientific Inc
  2. Pall Corporation
  3. PBS Biotech,Inc
  4. General Electric Company
  5. MERCK KGaA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Bioreactors Market